; or (B) an entity that is regulated by the agency exercises editorial control over the study or research. (i) With respect to a rulemaking under this section, an agency shall include in the notice of proposed rulemaking required under subsection (b) and in the final rule published under subsection (d) a description of how the agency considered scientific evidence, including any study or research. . (b) Application Subsections (g), (h), and (i) of section 553 of title 5, United States Code, as added by subsection (a), shall apply with respect to submissions made by interested persons on and after the date of enactment of this Act. 303. Disclosure of inter-governmental rule changes (a) Definitions In this section— (1) the term Administrator means the Administrator of the Office; (2) the terms agency , regulatory action , and significant regulatory action have the meanings given those terms in section 3 of the Executive Order; (3) the term Executive Order means Executive Order 12866 ( 5 U.S.C. 601 note; relating to regulatory planning and review); and (4) the term Office means the Office of Information and Regulatory Affairs. (b) Requirement With respect to any regulatory action that an agency provides to the Office under section 6(a)(3) of the Executive Order, and that the Administrator determines is a significant regulatory action under that section, the agency shall— (1) not later than the date on which the agency publishes the general notice of proposed rulemaking required under section 553(b) of title 5, United States Code, with respect to the action, place in the rulemaking docket— (A) the substance of any changes between the text of the draft regulatory action that the agency provided to the Office under section 6(a)(3)(B)(i) of the Executive Order and the text published in that general notice with respect to the action; and (B) a statement regarding whether any change described in subparagraph (A) was made at the request of— (i) the Office; (ii) another agency; or (iii) a Member of Congress